Type I IFNs play an important role in the immune response to enterovirus infections. Their importance is underscored by observations showing that many enteroviruses including coxsackie B viruses (CVBs) have developed strategies to block type I IFN production. Recent studies have highlighted a role for the type III IFNs (also called IFNls) in reducing permissiveness to infections with enteric viruses including coxsackievirus. However, whether or not CVBs have measures to evade the effects of type III IFNs remains unknown. By combining virus infection studies and different modes of administrating the dsRNA mimic poly I : C, we discovered that CVBs target both Toll-like receptor 3-and MDA5/RIG-I-mediated type III IFN expression. Consistent with this, the cellular protein expression levels of the signal transduction proteins TRIF and IPS1 were reduced and no hyperphosphorylation of interferon regulatory factor 3 was observed following infection with the virus. Notably, decreased expression of full-length TRIF and IPS1 and the appearance of cleavage products was observed upon both CVB3 infection and in cellular protein extracts incubated with recombinant 2A pro , indicating an important role for the viral protease in subverting the cellular immune system. Collectively, our study reveals that CVBs block the expression of type III IFNs, and that this is achieved by a similar mechanism as the virus uses to block type I IFN production. We also demonstrate that the virus blocks several intracellular viral recognition pathways of importance for both type I and III IFN production. The simultaneous targeting of numerous arms of the host immune response may be required for successful viral replication and dissemination.
INTRODUCTION
Coxsackieviruses are small positive-strand RNA viruses that belong to the genus Enterovirus in the family Picornaviridae. The coxsackievirus genome is approximately 7.5 kb and it encodes a single polyprotein. The polyprotein is cleaved by two virus-encoded proteases, 2A (2A pro ) and 3C (3C pro ), into structural and non-structural proteins (Pallansch & Roos, 2007) . Coxsackieviruses infect their hosts via the gastrointestinal tract. They have a broad tissue tropism and can cause severe diseases such as aseptic meningitis, myocarditis, hepatitis and pancreatitis (Huber, 2008; Pallansch & Roos, 2007) . Moreover, several observations have linked coxsackievirus infections to the development of chronic dilated cardiomyopathy (Chapman & Kim, 2008) and type 1 diabetes (Knip & Simell, 2012; Yeung et al., 2011) . Our understanding of the mechanisms behind virusinduced pathologies is limited, in part due to the lack of a complete understanding of how the virus interacts with the host.
The induction of type I IFN is an early immune response to a viral infection. In humans, type I IFNs comprise several IFNa subtypes and single isoforms of IFNb, -", -k and -! (de Weerd & Nguyen, 2012; Stetson & Medzhitov, 2006) . A more recently described group of IFNs is the type III IFNs, also called the IFNls. To date, this family has four members IFNl1 (IL29), IFNl2 (IL28a), IFNl3 (IL28b) and IFNl4 (Egli et al., 2014; Hermant & Michiels, 2014; Lazear et al., 2015) . Type III IFNs bind to a specific receptor, the IFNlreceptor (IFNlR) consisting of two subunits, IFNLR1 and IL10R2. While the type I IFN receptor (IFNAR) is expressed on all nucleated cells, the IFNlR is only expressed on some immune cells and cells of an epithelial origin such as hepatocytes and pancreatic islet cells (de Weerd & Nguyen, 2012; Li et al., 2009; Lind et al., 2013) . Similar to type I IFNs, the type III IFNs interfere with the replication of several viruses including hepatitis B, hepatitis C, rhinovirus and human immunodeficiency virus (Egli et al., 2014; Hermant & Michiels, 2014; Lazear et al., 2015) .
During a virus infection, IFN expression is induced upon intracellular recognition of the viral genome via pattern recognition receptors (PRR) (Lind et al., 2012) . A partially dsRNA intermediate is formed during coxsackievirus replication, and the sensing of coxsackieviruses has been suggested to be mainly mediated by Toll-like receptor 3 (TLR3) and the RIG-I-like (RLR) receptor melanoma differentiation associated protein 5 (MDA5) (e.g. Hühn et al., 2010; Negishi et al., 2008) . TLR3 is primarily expressed in the endosome where it recognizes dsRNA (Jensen & Thomsen, 2012) . In contrast, MDA5 and the other RLR reside in the cytoplasm. MDA5 senses long dsRNA, while RIG-I recognizes dsRNA containing a 5¢ triphosphate (Jensen & Thomsen, 2012) . Upon ligand engagement, TLR3 recruits TIR domain-containing adaptor inducing IFNb (TRIF, also known as TICAM) whereas MDA5 and RIG-I interact with mitochondrial antiviral signalling protein (IPS1, also know as MAVS, VISA and CARDIF). The signalling pathways converge in the activation of tank-binding kinase 1 (TBK1) and the inducible Ikb kinase (IKK) complex, which leads to activation of the transcription factors Interferon regulatory factor 3(IRF3) and NF-kB and the induced expression of type I and III IFNs (Jensen & Thomsen, 2012; Liu et al., 2015) .
In order to favour their own replication, most viruses have evolved mechanisms to counteract the host's immune response (Feng et al., 2014b; Hoffmann et al., 2015; Taylor & Mossman, 2013) . Previous studies have shown that enteroviruses such as the coxsackie B viruses (CVBs) block type I IFN production (Feng et al., 2014a; Mukherjee et al., 2011) . Recently, we reported that type III IFNs attenuate the replication of coxsackievirus B3 (CVB3) in primary human pancreatic endocrine cells (Lind et al., 2013) and hepatocytes (Lind et al., 2014) . Previous reports have indicated that some viruses may also inhibit the production of type III IFNs (Ding et al., 2012; Wang et al., 2011 Wang et al., , 2014 . Whether coxsackieviruses can subvert the hosts antiviral response by such a mechanism remains unknown.
Considering the emerging data supporting an important function of type III IFNs in the host immune response to coxsackieviruses (Lind et al., 2013 (Lind et al., , 2014 , we hypothesized that coxsackieviruses have evolved mechanisms to evade the type III IFN response. In the present study, we tested this hypothesis and, to our knowledge, we show for the first time that CVB3 inhibits the induction of type III IFNs. We also demonstrate that type I and III IFN production is blocked by similar mechanisms. On the basis of our studies, we propose a model for how the virus acts on different host signalling pathways in order to assure an efficient inhibition of the type III IFN response.
RESULTS
Poly I : C, but not CVB3, induces the expression of type III IFNs
We first investigated whether HeLa cells, which are highly permissive to CVB3, can initiate the expression of type III IFNs via TLR3-or MDA5/RIG-I-dependent mechanisms. Poly I : C added to cell cultures is taken up by endosomes and mainly recognized by TLR3, leading to the induction of downstream signalling events including the induced transcription of type III IFNs (Andrejeva et al., 2004; Dauletbaev et al., 2015; Gitlin et al., 2006) . If instead delivered to the cytosol via transfection, poly I : C is recognized by MDA5 and RIG-I, followed by the induction of an intracellular signalling cascade that induces transcription of genes encoding type III IFNs (Andrejeva et al., 2004; Dauletbaev et al., 2015; Gitlin et al., 2006) . Accordingly, the addition of poly I : C to HeLa cells, either exogenously or via transfection, induced the expression of IFNl1, IFNl2, as well as type I IFN (IFNb). The mRNA expression levels were increased already after 2 h, and a peak was reached at 4 h post-stimulation (Figs 1a, b, S1 available in the online Supplementary Material, and data not shown). Collectively, these experiments demonstrated that HeLa cells harbour intact cytoplasmic pathways to respond to dsRNA and express type I and III IFNs.
To determine if coxsackievirus induces the expression of type III IFNs we next infected HeLa cells with CVB3. We first performed pilot experiments to gain a better understanding for the CVB3 replication cycle in this cell line. Studies on the kinetics of virus protein-1 (VP-1) expression revealed that VP-1 is clearly detectable already at 4 h postinfection (p.i.) (Fig. S2) . The expression increased until 6 h p.i. and after this time point the percentage of positive cells declined in parallel with an increased cytopathic effect (CPE) (Fig. S2 , and data not shown). On the basis of these observations, the time point 4 h was selected for the mRNA expression studies. UV light-inactivated CVB3 (UV-CVB3) served as a negative control. In stark contrast tinto structural and nono poly I : C, CVB3 failed to induce a robust expression of IFNl1, IFNl2 (Fig. 1a) and IFNb (Fig. 1b) . As concluded from analyses of cells harvested at later time points (i.e. 6 and 8 h p.i.), there was no delay in the induced expression of the IFNs (Fig. S1 ). Collectively, these observations confirm previous studies showing that CVB3 blocks the expression of type I IFNs (Feng et al., 2014a) , and suggest that there is also a very limited type III IFN response after a CVB3 infection.
Poly I : C-induced type III IFN expression is inhibited in CVB3-infected cells
To address whether coxsackievirus has mechanisms that actively inhibit the induction of type III IFN expression, we next investigated whether a CVB3 infection blocks poly I : C-induced type III IFN mRNA expression. As coxsackievirus has been shown to induce signalling both via TLR3 and MDA5 (e.g. Hühn et al., 2010; Negishi et al., 2008) we studied both TLR3 and MDA5/RIG-I-mediated IFN induction and determined whether coxsackievirus has the ability to prevent these signalling pathways.
First, we investigated TLR3-mediated IFN expression. To this end, HeLa cells were infected with mock or CVB3 followed by stimulation with exogenous poly I : C (experimental set-up outlined in Fig. 2a) . A robust induction of IFNl1, IFNl2 and IFNb was detected upon mock infection followed by poly I : C stimulation (Fig. 2b) . In contrast, cells that had been infected with CVB3 prior to stimulation with poly I : C showed significantly lower levels of IFNl1, IFNl2 and IFNb mRNA expression (Fig. 2b) .
Next, we studied MDA5/RIG-I-mediated IFN expression. HeLa cells were mock infected or infected with CVB3 for 4 h followed by either mock transfection (Lipofectamine alone) or transfection with poly I : C for 3 h (experimental set-up outlined in Fig. 2c) . A strong induction of IFNl1, IFNl2 and IFNb mRNA was seen in cells that had been mock infected followed by transfection with poly I : C (Fig. 2d) . However, the IFNl1, IFNl2 and IFNb mRNA expression was substantially reduced in cells infected with CVB3 prior to transfection with poly I : C (Fig. 2d ). In summary, these studies suggested that CVB3 inhibits both TLR3-and MDA5/RIG-I mediated induction of type I and III IFN mRNA expression. ) in complex with Lipofectamine (Poly I : C) for another 3 h. RNA was isolated and the mRNA expression of IFNl1, IFNl2 and IFNb was measured using real-time RT-PCR. The mRNA expression levels were normalized to the mRNA expression level of GAPDH and then compared with those in Lipofectamine controls using the DDC t -method. Data are presented as fold induction (2 -DDCt ), mean ± SD of four independent experiments. ***P<0.01, ****P<0.0001, one-way ANOVA with Bonferroni correction (selected comparisons indicated in figure) . NS, Not significant.
CVB3 infection fails to induce hyperphosphorylation of IRF3
Type III IFN expression is dependent on the activation of the transcription factor IRF3 (reviewed by Lazear et al., 2015) . IRF3 is constitutively expressed and resides primarily in the cytosol of unstimulated cells. Upon stimulation, IRF3 is phosphorylated at multiple sites in the C-terminal domain (hyperphosphorylation) and this is required for dimerization, transmigration to the nucleus and binding to elements in the promoter regions of genes such as the type I IFN genes (Jensen & Thomsen, 2012; Liu et al., 2015) .
The phosphorylation status of IRF3 can be studied using SDS-PAGE and Western blotting. Earlier studies have shown that the mobility of IRF3 is sensitive to phosphorylation and that phosphorylated IRF3 migrates more slowly than unphosphorylated IRF3 (Lin et al., 1999; Servant et al., 2001 ).
To determine whether IRF3 is phosphorylated upon coxsackievirus infection, HeLa cells were infected in mock or with CVB3. Protein was isolated every other hour up to 8 h p.i. and the phosphorylation of IRF3 was studied. Transfection with poly I : C served as positive control. As shown in Fig. 3(a) , two bands, designated form I and II (Servant et al., 2001) , were detected when blotting for IRF3 in mock-treated cells. Form I has previously been shown to represent unphosphorylated IRF3, whereas form II is phosphorylated IRF3 (Servant et al., 2001) . Upon transfection with poly I : C, a more slowly migrating form of IRF3 was detected, representing the hyperphosphorylated form of IRF3 ( Fig. 3a) and previously designated form III (Servant et al., 2001) . While modifications of the IRF3 phosphorylation status were observed in cells infected with CVB3, we mainly detected an increase in the phosphorylated form (form II) and little if any of the hyperphosphorylated form (form III, Fig. 3a ). This phosphorylation pattern was observed at 4 h p.i. and remained stable up to 6 h p.i. (Fig. 3b) . The phosphorylation of IRF3 (form II) was dependent on viral replication, as it was not observed in cells infected with a UV-inactivated CVB3 (data not shown). In summary, these results suggested that CVB3 has developed mechanisms that result in a failure of the infected cell to hyperphosphorylate IRF3, which is a prerequisite for successful induction of gene transcription.
The expression of TRIF protein is affected by CVB infection
We next wished to gain mechanistic insight as to how CVB3 prevents the induction of type III IFNs and investigated whether CVB3 targets signalling molecules upstream of IRF3.
To study whether coxsackievirus targets the TLR3-signalling pathway, HeLa cells were infected with mock or CVB3, and protein was isolated every other hour up to 8 h p.i. We first made an attempt to measure TLR3 protein expression following infection; however, the antibody directed to TLR3 did not work in our hands [TLR3 mRNA expression was, however, confirmed via real-time reverse transcription (RT)-PCR, data not shown]. A previous study suggested that TRIF is cleaved following CVB3 infection (Mukherjee et al., 2011) . Therefore, we went on to study whether CVB3 infection alters the protein levels of TRIF. As shown in Fig.  4(a) , the protein level of full-length TRIF declined following CVB3 infection, starting at 4 h p.i. and was being further reduced at 6 and 8 h p.i. The appearance of an additional band of approximately 70 kDa was detected in lysates from infected cells (Fig. 4a) , suggesting that TRIF is cleaved during infection.
We next investigated if the alterations in TRIF protein abundance upon CVB3 infection could be confirmed in another cell line, HepG2 cells, and in HeLa cells with other serotypes of CVB (CVB1 and CVB4). As shown in Figs S3 and S4, the results were in line with the previous studies and showed that the protein levels of TRIF were reduced following CVB3 infection. The somewhat slower kinetics in HepG2 cells compared with HeLa cells may be explained by a slower viral replication cycle in HepG2 cells compared with HeLa cells (Richardson et al., 2014;  Fig. S5 ). In summary, these studies showed that CVB3 infection results in lower cellular levels of the key transduction molecule TRIF, and that TRIF may be cleaved during infection. 
CVB3 infection negatively affects the protein expression level of IPS1
We next assessed whether the RLR pathway is targeted during an infection with CVB3. As RIG-I and MDA5 both activate IPS1, we analysed the protein expression levels of IPS1 in HeLa cells infected by CVB3 using Western blot analysis. This analysis revealed that the amount of full-length IPS1 protein declined following CVB3 infection. Lower levels were evident from 4 h p.i. and onwards, and were paralleled by the appearance of cleavage products (Fig. 4b ).
To confirm in a different cell line that CVB3 infection results in reduced levels of full-length IPS1, HepG2 cells were infected with CVB3 and protein was isolated every other hour up to 12 h p.i. As shown in Fig. S3 , the protein levels of IPS1 decreased from 6 h p.i. and were further reduced throughout the study period. We also observed a similar decrease in IPS1 expression in HeLa cells infected with other CVB serotypes (CVB1 and CVB4, Fig. S4 ).
In addition to lower levels of IPS1 we also observed decreased protein levels of RIG-I following infection with CVB3. This was evident at 4 h p.i., and a further decrease was observed at 8 h p.i. (Fig. S6a) . The infection also lead to slightly reduced protein levels of MDA5, but this was not observed until 6 h p.i. (Fig. S6b) . In summary, these data suggested that coxsackievirus targets MDA5/RIG-I mediated signalling by cleaving IPS1 and downregulating RIG-I and MDA5 protein levels.
The reduced expression of full-length TRIF and IPS1 following CVB3 infection is independent of caspase and proteasome activity Caspases are activated during apoptosis, which leads to cleavage of specific proteins such as poly(ADP ribose) polymerase (PARP). Some enteroviruses including poliovirus have been shown previously to induce proteasome-and/or caspase-dependent degradation of MDA5 (Barral et al., 2007; Drahos & Racaniello, 2009; Rebsamen et al., 2008) . To determine whether activation of cellular caspases or degradation of proteins via the proteasome could have contributed to the cleavage of IPS1 and TRIF in CVB3-infected cells, HeLa cells were infected with CVB3 in the presence of Z-VAD, a caspase inhibitor, or MG132, a proteasome inhibitor. As a positive control, HeLa cells were treated with puromycin, an inducer of apoptosis.
To verify that apoptosis was induced we studied the cleavage of PARP. Indeed, cleavage of PARP was observed after treatment with puromycin for 8 h, which was inhibited in the presence of Z-VAD, but not with MG132 (Fig. S7) . Infection with CVB3 also leads to some cleavage of PARP, which was to some extent blocked by treatment with Z-VAD and MG132 (Fig. 5) .
A reduced expression of full-length TRIF was observed after infection with CVB3 and it was unaffected by the presence of Z-VAD or MG132 (Fig. 5) . Similarly, the reduced expression of IPS1 was not affected by the addition of Z-VAD or MG132 (Fig. 5) . Furthermore, the expression of VP-1 was unaltered when Z-VAD or MG132 was added to the cells (Fig. 5) , indicating that the treatment did not affect virus replication. Collectively, these experiments demonstrated that the reduced expression of IPS1 and TRIF following a CVB3 infection is independent of caspase and proteasome activity.
Coxsackievirus 2A pro inhibits poly I : C-induced type III IFN expression
The coxsackievirus-encoded proteases 2A
pro and 3C pro process the viral polyprotein but can also target cellular proteins to, for example, block transcription and translation (Joachims et al., 1999; Kr€ ausslich et al., 1987) . The appearance of TRIF and IPS1 cleavage products (Fig. 4) led us next to hypothesize that the proteases are responsible for blocking the induction of type III IFNs in CVB3-infected cells. In order to test this hypothesis, we constructed GFPexpressing plasmid vectors carrying genes encoding either 2A pro or 3C pro , which were transfected into HeLa cells. First, we studied the effect of the proteases on TLR3-mediated signalling. To this end, cells were transfected with 2A pro or 3C pro and then treated with mock or poly I : C (experimental set-up outlined in Fig. 6a ). Using PCR and specific primers we confirmed the expression of 2A pro and 3C pro in transfected cells (Fig. S8a ). Samples were analysed for the presence of plasmid by the omission of the reverse transcriptase from the RT reaction followed by PCR analysis using protease-specific primers. No transcripts were observed, confirming that contaminating plasmid DNA was not responsible for the amplified signal in positive samples (data not shown). Moreover, in initial experiments, the cleavage of eIF4G (Kr€ ausslich et al., 1987) or G3BP (White et al., 2007) was used as positive controls for the cloned 2A pro and 3C pro , respectively (Fig. S8b, c) . As presented in Fig. 6(b) , the expression of 2A pro significantly suppressed poly I : C-mediated induction of IFNl1, IFNl2 and IFNb mRNA expression. The expression of 3C pro did, however, not have an effect on poly I : C-mediated IFN induction.
In a similar manner, the effect of CVB3 2A pro and 3C pro on MDA5/RIG-I mediated signalling was studied. HeLa cells were transfected with empty vector or vector expressing 2A pro or 3C pro , and then transfected in mock (Lipofectamine alone) or with poly I : C (experimental set-up outlined in Fig. 6c ). The expression of 2A pro strongly dampened the induction of IFNl1, IFNl2 and IFNb mRNA expression induced by transfected poly I : C. In contrast, no inhibitory effect was detected in cells expressing 3C pro (Fig. 6d) . Collectively, these experiments suggested that expression of coxsackievirus 2A pro inhibits TLR3 and MDA5/RIG-I mediated induction of type III IFN transcription.
CVB3 2A pro causes a reduced protein expression of IPS1 and TRIF
To further investigate the role of 2A pro in inhibiting type III IFN induction we produced 2A pro and incubated HeLa cell lysates with the protease. In line with the overexpression studies, the incubation resulted in lower levels of both TRIF (Fig. 7a) and IPS1 (Fig. 7b) and was accompanied by the appearance of cleavage products. Together, these results demonstrated that CVB3 2A pro has an effect similar to live virus and suggest that 2A pro may mediate the decreased levels of intact IPS1 and TRIF seen in CVB3-infected cells.
DISCUSSION
In the present study we demonstrated that coxsackieviruses inhibit the expression of type III IFNs. Our study also provides insight into the strategy by which such viruses evade this host antiviral immune response, and the data suggest that this is achieved by a similar mechanism as previously infection is independent of caspase and proteasome activity. HeLa cells were infected with medium alone (mock) or CVB3 at an m. o.i. of 20 for 1 h; at the same time inhibitors of caspase activity (Z-VAD, 50 µM) or proteasome activity (MG132, 10 µM) were added to the cells. The cells were then washed and cultured in fresh media supplemented with Z-VAD and MG132 at the same concentrations as before. Cells were lysed at 8 h p.i., and protein expression of TRIF, IPS1, PARP and VP-1 was analysed using SDS-PAGE and Western blotting. Actin was used as loading control. Arrows indicate possible degradation/cleavage products. One representative experiment out of three independent experiments with similar results is shown. Molecular mass (kDa) is shown to the left.
reported for type I IFNs (Feng et al., 2014a) . We showed that the expression levels of TRIF and IPS1, two proteins with key functions in the intracellular signalling downstream of TLR3 and MDA5/RIG-I, respectively, are reduced following coxsackievirus infection. Moreover, we demonstrated that the coxsackievirus-encoded protease 2A pro is responsible for the reduced expression of IPS1 and TRIF, as well as a block in poly I : C-induced type III IFN expression. ) for an additional 3 h. RNA was isolated and the mRNA expression of IFNl1, IFNl2 and IFNb was measured using real-time RT-PCR. The mRNA expression levels were normalized to the mRNA expression level of GAPDH and then compared with those in cells transfected with empty vector (pCMS) using the DDC t -method. Data are presented as percentage of control [empty vector (pCMS), mean ± SD], n = 3. * P<0.05, ** P<0.01, one-way ANOVA with Bonferroni correction (selected comparisons indicated in figure) . NS, Not significant.
Collectively, our studies suggest that CVB3 utilizes 2A pro to suppress both TLR3-and MDA5/RIG-I-mediated signalling leading to an inability to respond to infection via the induced expression of type III IFN.
Type III IFNs display similar antiviral properties as type I IFNs (Kotenko, 2011) and an increasing number of studies indicate that type III IFNs provide protection against several viruses, including picornaviruses (Díaz-San Segundo et al., 2011; Lind et al., 2013 Lind et al., , 2014 . Whether or not viruses have evolved mechanisms to block the production of type III IFNs is less studied. Hepatitis C virus and foot-and-mouth disease virus have been shown to negatively regulate IFNl1 expression (Ding et al., 2012; Wang et al., 2011 Wang et al., , 2014 , and by demonstrating that CVB3-infected cells fail to express both IFNl1 and IFNl2, our study shows that coxsackieviruses have also developed mechanisms to antagonize the induction of type III IFNs.
The transcription factor IRF3 is important for the induction of type III IFNs (Lazear et al., 2015) , and activation of IRF3 is dependent on phosphorylation at multiple sites (hyperphosphorylation) (Lin et al., 1999; Liu et al., 2015; Servant et al., 2001) . Here, we studied the phosphorylation pattern of IRF3 following CVB3 infection and, to our knowledge, provide the first evidence that hyperphosphorylation of IRF3 does not occur after CVB3 infection (Fig. 3) . The lack in hyperphosphorylation suggests that IRF3 is not fully activated following CVB3 infection and is in line with previous studies showing impaired IRF3 activation following CVB3 challenge (Feng et al., 2014a; Mukherjee et al., 2011) . Based on our observations, we hypothesized that proteins upstream of IRF3 activation are targeted during a coxsackievirus infection.
Both TLR3 and MDA5 contribute to the recognition of coxsackievirus (e.g. Hühn et al., 2010; Negishi et al., 2008 ). Our present studies using different ways to administer poly I : C suggested that the expression of type III IFNs can be induced via both these pathways (Fig. 1) . From this we hypothesized that the virus would need to block both pathways in order to efficiently prevent type III IFN production following a CVB3 infection (Fig. 8) . Consistent with these assumptions, our studies demonstrated that both TLR3-and MDA5/RIG-I-mediated pathways are targeted during infection: we observed that neither exogenously added poly I : C (mainly detected by TLR3) nor transfected poly I : C (detected by MDA5/RIG-I) induced a robust expression of type III IFNs in cells that had been infected with CVB3 (Fig.  2b, d ). In addition, we detected lower protein levels of TRIF and IPS1 in CVB3-infected cells, which was accompanied by the appearance of possible cleavage products (Fig. 4a, d ). This was not limited to CVB3 but also observed after infection with other CVB serotypes (Fig. S4) . Reduced protein expression levels of TRIF and/or IPS1 have previously been linked to a block in type I IFN expression in enterovirusinfected cells (Lei et al., 2011; Mukherjee et al., 2011; Xiang et al., 2014) . Our results support the notion that coxsackieviruses disrupt TLR and MDA5/RIG-I signalling by targeting the adaptor molecules TRIF and IPS1, respectively. Importantly, our study also suggests that by blocking these two pathways the virus prevents the cell from expressing type III IFNs (Fig. 8) .
Studies with polio-and rhinovirus have suggested that reduced expression of IPS1 is dependent on the activation of cellular caspases (Drahos & Racaniello, 2009; Rebsamen et al., 2008) . However, using a caspase inhibitor we demonstrated that the CVB3-induced reduction of TRIF and IPS1 expression was not dependent on caspase activation (Fig.  5) . Our studies also excluded a major role for degradation via the ubiquitin proteasomal pathway (Fig. 4) . Host proteins important for type I IFN induction have been identified as targets for coxsackievirus 2A pro and 3C pro (Feng et al., 2014a; Lei et al., 2011; Mukherjee et al., 2011; Wang et al., 2013) , making the proteases likely candidates for inhibiting type III IFN induction as well. When overexpressing 2A pro we found that poly I : C-induced type III IFN expression was severely inhibited (Fig. 6b, d) . In parallel to this, we observed that the protein levels of both TRIF and IPS1 were reduced upon overexpression of 2A pro or incubation with recombinant 2A pro (Fig. 7) . The 3C pro did not appear to have the same effect as no change in TRIF and IPS1 protein levels (Fig. 7) and poly I : C-induced type III IFN was observed following expression of this protease (Fig.  6b, d ). Taken together, these studies suggest that coxsackieviruses use 2A pro to evade the type III IFN response.
Previous studies have suggested that TRIF and IPS1 are targeted by coxsackieviruses, but conflicting results have been obtained in studies assessing the involvement of 2A pro and 3C pro (Feng et al., 2014a; Mukherjee et al., 2011) . Our findings support the studies by Feng et al. (2014) , which showed that degradation of IPS1 is mediated by 2A pro , and similar observations have been made with 2A
pro from enterovirus 71 (Wang et al., 2013) . Our study suggests that TRIF is also targeted by 2A pro (Fig. 7) . This is in contrast with the findings of Mukherjee et al. (2011) , who suggested that TRIF was cleaved by 3C
pro . An important difference between this and our study is that Mukherjee et al. (2011) studied the effect of 3C
pro at 48-72 h post-transfection, whereas we studied the effect at 18 h post-transfection. In our hands, 3C pro was highly expressed already at 15 h post-transfection and at this time the cells were still viable. At 18 h posttransfection we also saw a clear effect of 2A pro but not 3C pro on poly I : C-induced IFN transcription. Transfected cells that were kept for longer than 18 h showed increasing cell death over time. It is possible that transfection of 3C pro for longer than 18 h induces apoptosis which may contribute to degradation of TRIF.
Of note, the expression levels of the intracellular receptors MDA5 and RIG-I were also slightly decreased following CVB3 infection (Fig. S5b, c) . Similar observations have been made previously (Feng et al., 2014a) , and in congruence with our observations this decrease became evident only later in the virus replication cycle (present study: 4-6 h p.i.; Feng et al., 2014a: 9 h p.i.) , at time points when the virus is near to completion of its replication cycle (compare Fig. S2) . Hence, the implications of a decreased PRR expression during an acute infection are at present unclear. One possibility is that this is a mechanism that would be favourable in a situation when the virus is establishing persistence. Further studies are needed to clarify the meaning of a decreased PRR expression late in the virus replication cycle.
Type III IFNs predominantly act on cells of epithelial origin, including cells lining the mucosal surface of the intestine (Lazear et al., 2015) . Coxsackieviruses infect primarily via the faecal-oral route, and oral lymph nodes as well as the epithelial cell layer lining the intestinal wall represent the primary sites of replication for these viruses. A previous study identified a non-redundant function of type III IFNs in protecting intestinal epithelial cells from rotavirus infection (Pott et al., 2011) , and we have found that type III IFNs protect human intestinal epithelial cell lines from coxsackievirus infection (V. M. Stone and others, unpublished). In a recent study it was shown that type III IFNs, but not type I IFNs, control persistent norovirus infection, and that type III IFNs could cure a persistent infection independent of adaptive immunity (reviewed by Lazear et al., 2015) . Here we show that coxsackieviruses block the type III IFN expression. Hence, blockage of type III IFN production in the intestinal tract may be an important mechanism that coxsackieviruses have evolved to facilitate replication and spread to other sites within the host. Future studies are required to address this hypothesis.
To summarize, our study demonstrates that coxsackieviruses block the expression of type III IFNs. We also show that the virus targets several PRR-induced pathways to evade the type III IFN response, and that the mechanisms used to block type III IFNs are similar to those that have been shown to prevent type I IFN production (summarized in Fig. 8 ). Together with a general inhibition of transcription and translation, the simultaneous blocking of type I and III IFN production may undermine cellular antiviral defence mechanisms and favour viral replication and spread.
METHODS
Cell culture. HeLa and HepG2 cells were grown in RPMI 1640 (HyClone, Nordic Biolabs) supplemented with 10 % inactivated FBS, 2 mM L-glutamine, 100 U penicillin ml
À1
, 100 µg streptomycin ml
and 10 mg normocin ml
, alternatively with the same supplements without antibiotics, at 37 C and 5 % CO 2 . Cells were passaged three times a week.
Virus stock, virus titration and UV-light inactivation of virus.
CVB1 (ATCC), CVB3 (Nancy) and CVB4 (E2) were propagated in HeLa cells and the titre of the stocks was determined using a standard plaque assay using HeLa cells. Inactivation of CVB3 replication was performed by exposing an aliquot of the virus stock to UV light for 15 min. During this time, the virus was mixed every 2-3 min. The concentration of infectious virus particles after UV-inactivation was below the detection limit of our plaque assay (2.5 p.f.u. ml were cloned separately into the pCMS-EGFP vector using the MluI and XhoI restriction sites. The GFP-G3BP plasmid was kindly provided by Dr G. McInerney (Karolinska Institutet, Stockholm, Sweden). Transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. A total of 4 µg plasmid was used for transfections with single plasmids. When two plasmids were co-transfected (e.g. 3C pro and GFP-G3BP), 4 µg of the protease-expressing plasmid and 0.5 µg of the target plasmid were used. The transfection efficiency was assessed using PCR, flow cytometry (GFP) and/or Western blotting as described below. In initial experiments, time-course studies identified 15 h post-transfection as a time point when GFP was strongly expressed but no or low CPE was observed (data not shown). Flow cytometry. Cells were fixed and directly analysed by flow cytometry to detect GFP-positive cells. Alternatively, the cells were fixed and permeabilized using Cytofix/Cytoperm (BD) followed by intracellular staining with a mAB to VP-1 (clone 5-D8/1, DAKO), followed by a goat anti-mouse Alexa 647-conjugated secondary antibody (Invitrogen), as previously described (Hühn et al., 2008) . VP-1-or GFP-positive cells were detected using a FACS Calibur (BD) and analysed with FlowJo version 9.5.1 (Treestar).
RNA isolation, real-time and traditional RT-PCR. Isolation and quantification of RNA, and cDNA synthesis were described previously (Lind et al., 2013) . Pre-designed primers (Quantitech Primer Assay, Qiagen) were used to detect IFNb, IFNl1, IFNl2 and GAPDH using realtime PCR. Each gene was first normalized to the expression levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (DC t ) and then the gene expression in CVB3-infected cells was compared with that of mock-treated cells (DDC t ). The data are presented as fold induction: 2
ÀDDCt
. A C t value of ! 35 was considered as below the detection level of the assay and samples with a C t value of ! 35 were arbitrarily set to 35.
The 2A and 3C mRNA expression in cells transfected with plasmids encoding either protease was analysed by traditional RT-PCR. cDNA was prepared as described previously (Lind et al., 2013) . Amplification was performed using primers specific for 2A pro and 3C pro in a PCR-reaction consisting of Taq DNA polymerase (0.5 U; Invitrogen), MgCl 2 (1 mM; Invitrogen), dNTPs (0.16 mM of each; Invitrogen), 1 Â Taq PCR buffer (Invitrogen), primers (0.1 µM of each), cDNA (0.5 µl) and water (up to 10 µl). Primer sequences: 2A for, GACAACAATCAGGGG-CAGTG; 2A rev, TGTGCACTGACATCTGGCTA; 3C for, ACACCAG-CAAGTTTCCCAAC; 3C rev, TGGCCATTTCCACCAACATG. The following thermal cycling conditions were used: 92 C for 5 min, followed by 25 cycles of 95 C for 30 s followed by 30 s at 60 C or 65 C for 2A pro and 3C pro , respectively, and 72 C for 20 s. The reaction was then ended with 72 C for 5 min. The final PCR products were separated on an agarose gel, detected with Gel Green (1 : 10 000; Biotium) and visualized using a LAS-4000 imaging system (Fujifilm).
Caspase and proteasome inhibition. HeLa cells were plated in sixwell plates. The day after, the cells were infected with medium alone (RPMI 1640) or CVB3 (as described above) at an m.o.i. of 20 or treated with puromycin (2 µg ml À1 ; Sigma). At the same time the cells were treated with DMSO, Z-VAD (50 µM; Calbiochem) or MG132 (10 µM; Sigma). After 1 h the cells were washed three times using PBS, and 2 ml complete media supplemented with DMSO, Z-VAD or MG132 at the same concentrations as before was added. The cells were harvested at 4 and 8 h p.i. and protein was isolated for Western blot analysis, as described below.
Production of 2A pro and in vitro digestion. Protein production was performed at the Protein Science Facility at Karolinska Institutet/ SciLifeLab (http://psf.ki.se). In brief, the coxsackievirus B3 (Woodruff strain) 2A
pro was cloned into the pNIC28-Bsa4 vector, which was then used to transform BL21(DE3) R3 pRARE2 phage-resistant Escherichia coli (chloramphenicol resistant). Inoculation of cultures from fresh transformants were grown overnight at 30 C, 175 r.p.m. in 3000 ml of bacteria culture media containing 50 µg kanamycin ml À1 and 34 µg chloramphenicol ml
À1
. Next day cultures were grown in the LEX system (Harbinger Biotechnology) (37 C), and when the OD reached 0.7 the temperature was lowered to 18 C and 1 µM ZnCl 2 added. Protein expression continued overnight. Cells were then harvested by centrifugation (10 min at 4500 g) and resuspended in IMAC lysis buffer (Sigma) containing complete EDTA-free protease inhibitor cocktail (Roche) and 250 U benzonase nuclease (Sigma).
Cells were disrupted by pulse sonication followed by centrifugation and filtering through a 0.45 µm filter. The samples were loaded onto ÄKTA Xpress (GE Healthcare) and purified overnight; the IMAC column used was a 5 ml HisTrap (GE Healthcare) and the gel filtration column was a HiLoad 16/60 Superdex 75 (GE Healthcare). The His tag was removed using TEVsh protease and the cleaved protein further purified using a HisTrap column (GE Healthcare). Buffer was changed using an Amicon Ultra centrifugal filter with MWCO 30.000 (Merck Millipore). Purified protease was collected in a buffer consisting of 25 mM HEPES, 140 mM NaCl, 1 µM ZnCl 2 and 2 mM TCEP.
HeLa cell protein lysate was incubated for 1 h at 37 C with the amount of protease indicated in assay buffer: 20 mM HEPES (pH 7.4), 150 mM potassium acetate and 1 mM DTT. Proteolysis was analysed by Western blotting as described below.
Antibodies, SDS-PAGE and Western blot analysis. Protein isolation, separation and detection of proteins using Western blot analysis were performed as described previously (Lind et al., 2013) . The primary antibodies used were: IPS1 (1 : 2000; Alexis Biochemicals), TRIF (1 : 1000; Cell signal), MDA5 (1 : 1000; Alexis Biochemicals), RIG-I (1 : 1000; Alexis Biochemicals), eIF4G (1 : 1000; Cell signal), G3BP (1 : 1000; Aviva Systems Biology), PARP (1 : 1000; Cell signal), VP-1 (1 : 400; DAKO), 3C (1 : 2000; generated in-house) and actin (1 : 30.000; MP Biomedicals). The secondary antibodies used were: HRP-conjugated goat anti-mouse (1 : 1000 or 1 : 10.000; Bio-Rad) and goat anti-rabbit antibody (1 : 1000; Bio-Rad).
Statistical analysis. Statistical analysis was performed using GraphPad Prism 5. A normality test (Kolmogorov-Smirnov test) was used to determine whether the datasets were normally distributed. For data that was normally distributed, multiple comparisons were made using oneway ANOVA with Bonferroni correction. For data that did not show normal distribution using the normality test or contained too few observations to perform normality tests, multiple paired comparisons were made using a non-parametric test (Friedman test) with Dunn's correction. Data are presented as mean ± SD.
